Not applicableStudy completedNCT02695849What this trial is testingPrevalence of EGFR Mutations in Participants With NSCLCWho this might be right forNon-Small Cell Lung Cancer Hoffmann-La Roche 69
Very early researchLooking for participantsNCT07077616What this trial is testingClinical Study for the Safety and Therapeutic Efficacy of the AI-QMMM Designed TamavaqTM Personalised Vaccine in Patients With Newly Diagnosed Glioma.Who this might be right forGlioma Biogenea Pharmaceuticals Ltd. 29
Not applicableLooking for participantsNCT03177902What this trial is testingEvaluation of Thyroid Abnormity Incidence and Thyroid Toxicity During Chemotherapy Among Newly Diagnosed Breast CancerWho this might be right forBreast Cancer FemaleThyroid Gland The First Affiliated Hospital of Bengbu Medical University 400
Testing effectiveness (Phase 2)Looking for participantsNCT05332561What this trial is testingGenomics Guided Targeted Post-neoadjuvant Therapy in Patients With Early Breast Cancer (COGNITION-GUIDE)Who this might be right forEarly-stage Breast Cancer German Cancer Research Center 240
Large-scale testing (Phase 3)Study completedNCT00522951What this trial is testingSH L 562BB Phase II/III Dose Justification and Gadoteridol-controlled Comparative StudyWho this might be right forBrain Metastases Bayer 165
Not applicableActive Not RecruitingNCT06762470What this trial is testingPrognostic Value of CD4/CD8 Ratio in Patients with Nasopharyngeal CarcinomaWho this might be right forHistopathological Diagnosis of Nasopharyngeal CarcinomaPatients with Nasopharyngeal Carcinoma Without Distant Metastases After AJCC/UACC 8th Edition Jiangxi Provincial Cancer Hospital 325
Testing effectiveness (Phase 2)Ended earlyNCT04352205What this trial is testingDaratumumab-Based Therapy for the Treatment of Newly Diagnosed Multiple Myeloma With Kidney FailureWho this might be right forPlasma Cell MyelomaRenal Failure Emory University 17
Not applicableStudy completedNCT03349931What this trial is testingProspective Multicenter Evaluation of the MycoGenie Kit for the Diagnosis of Invasive AspergillosisWho this might be right forInvasive Aspergillosis in Patients With Onco-haematological Diseases Assistance Publique - Hôpitaux de Paris 350
Not applicableStudy completedNCT01304654What this trial is testingALI (Acute Lung Injury) /ARDS (Acute Respiratory Distress Syndrome) in Oncologic Pediatric PatientsWho this might be right forAcute Lung InjuryAcute Respiratory Distress SyndromeNeoplasms Grupo de Apoio ao Adolescente e a Crianca com Cancer 29
Testing effectiveness (Phase 2)Looking for participantsNCT06136351What this trial is testingThe Zanubrutinib Given in Combination With Bendamustine and Rituximab in (Elderly or TP53 Alterations or Chemotherapy Intolerance) Patients With Newly Diagnosed Mantle Cell LymphomaWho this might be right forLymphoma, Mantle-Cell Ruijin Hospital 23
Not applicableUnknownNCT01388101What this trial is testingReal-time Diagnosis of Serum LECT 2 in Patient With Liver Cancer Using Electronic Antibody Sensor (e- Ab Sensor)Who this might be right forLiver Cancer National Taiwan University Hospital 80
Testing effectiveness (Phase 2)Study completedNCT01527149What this trial is testingOfatumumab in Combination With Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine Sulfate, and Dexamethasone Alternating With Ofatumumab in Combination With Cytarabine and Methotrexate in Treating Patients With Newly Diagnosed Mantle Cell LymphomaWho this might be right forStage I Mantle Cell LymphomaStage II Contiguous Mantle Cell LymphomaStage II Non-Contiguous Mantle Cell Lymphoma+2 more Roswell Park Cancer Institute 37
Large-scale testing (Phase 3)Study completedNCT02688140What this trial is testingStudy for Patients With Newly Diagnosed, High-risk Acute Promyelocytic LeukemiaWho this might be right forAcute Promyelocytic Leukemia Technische Universität Dresden 133
Large-scale testing (Phase 3)Study completedNCT00481247What this trial is testingA Phase III Study of Dasatinib vs Imatinib in Patients With Newly Diagnosed Chronic Phase Chronic Myeloid LeukemiaWho this might be right forMyeloid Leukemia, Chronic Bristol-Myers Squibb 547
Not applicableLooking for participantsNCT05127148What this trial is testingRWE of Pediatric-like Protocol for AYA Patients With Ph-negative ALLWho this might be right forAcute Lymphoblastic Leukemia, Adult Grupo Argentino de Tratamiento de la Leucemia Aguda 100
Testing effectiveness (Phase 2)Looking for participantsNCT05576974What this trial is testingA Phase 2a, Single-dose, Open-label Study to Evaluate Diagnostic Performance and Safety of Pegsitacianine, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer, in Patients With Unknown Primary Head and Neck Cancer (ILLUMINATE STUDY)Who this might be right forHead and Neck CancerUnknown Primary CancerHead and Neck Squamous Cell Carcinoma University of Texas Southwestern Medical Center 120
Not applicableStudy completedNCT04539678What this trial is testingSYTHROM Cohort, Myeloproliferative Neoplasia With Normal CBC and Thrombotic ComplicationsWho this might be right forThrombotic PatientsDiagnosis of Myeloproliferative NeoplasiaImpact of Treatment With Cytoreducing Agent Nantes University Hospital 253
Large-scale testing (Phase 3)Study completedNCT01450449What this trial is testingShort Course vs. Standard Course Radiotherapy in Elderly and/or Frail Patients With Glioblastoma MultiformeWho this might be right forGlioblastoma Multiforme International Atomic Energy Agency 115
Not applicableStudy completedNCT01020097What this trial is testingFluorine F 18 EF5 Positron Emission Tomography in Assessing Hypoxia in Patients With Newly Diagnosed Stage I, Stage II, Stage III, or Stage IV Head or Neck Squamous Cell Cancer of the Oral Cavity, Oropharynx, and LarynxWho this might be right forSquamous Cell Carcinoma Abramson Cancer Center at Penn Medicine 5
Early research (Phase 1)Study completedNCT02236013What this trial is testingASP2215 in Combination With Induction and Consolidation Chemotherapy in Patients With Newly Diagnosed Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia Astellas Pharma Global Development, Inc. 80